EG BioMed U.S. CLIA/CAP-Certified Laboratory Opens Partnership Opportunities
Exhibitor: EG BIOMED US INC.
Date: 2026-06-15
Booth No.: M709
EG BioMed US Inc., located near Seattle, Washington, operates a CLIA-certified and CAP-accredited laboratory and is now welcoming biotechnology companies, diagnostic developers, academic researchers, and industry partners to join its Shared Laboratory Program.
The facility offers shared laboratory benches, high-throughput extraction and qPCR systems, blood sample processing areas, office space, and emergency power backup systems designed to support clinical research, validation studies, and regulatory readiness.
Supported by U.S.-licensed pathologists and laboratory scientists with extensive experience in FDA, LDT, CLIA, and CAP requirements, EG BioMed helps partners accelerate validation, clinical testing, and market entry into the United States.
The program is suitable for:
• Biotechnology startups
• Molecular diagnostics developers
• Precision medicine innovators
• Academic and translational research groups
• Companies expanding into the U.S. market
Visitors are welcome to meet the EG BioMed team during BIO Asia–Taiwan and learn more about partnership opportunities and laboratory resources.
More Exhibitor's Press Release
- Bridging the U.S. and Global Markets: EG BioMed Builds an International Precision Cancer Testing Ser EG BIOMED US INC. / 2026-06-15
- Blood-Based Early Cancer Detection: Advancing Precision Health Through DNA Methylation Science EG BIOMED US INC. / 2026-06-15
- BrainChild XH13 Cloud Logger Delivers Environmental Visibility for Labs and Storage BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-11
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-11
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-11
- 2026 BIO Asia: Next-Gen 3D Cell Culture & Exosome Solutions by LIS TECH & GeniCore Biotech LIS TECH CO., LTD. / 2026-06-04
- Botanical Drug GM-XANTHO® Completes Phase I/IIa Trial for Atopic Dermatitis XANTHO BIOTECHNOLOGY CO., LTD. / 2026-06-04
- ProBio and Curocell Achieve Key CAR-T Milestone with BLA Regulatory Approval and Commercial Readines PROBIO TECHNOLOGY HK LIMITED. / 2026-06-04
- LIS TECH Showcases Regenerative Medicine and Bioprocessing Platform at BIO Asia–Taiwan 2026 LIS TECH CO., LTD. / 2026-06-03
- GeniCore Biotech Unveils Its AI-Powered Genimer™ Aptamer Platform LIS TECH CO., LTD. / 2026-06-03
- Medidata’s Digital Oversight Platform Empowers Pharma and CROs to Align with Next-Gen GCP MEDIDATA / 2026-06-02
- Medidata Powers Transformational Breakthroughs in Over 500 Global Clinical Trials with AI MEDIDATA / 2026-06-02
- Empowering eCOA to Deliver Flexible and Efficient Digital Solutions MEDIDATA / 2026-06-02
- Save the Date: LabWare Professional Seminar Coming This September! LABWARE TAIWAN CO., LTD. / 2026-05-29
- LabWare Named Best IT Solution at the Labmate Awards for Excellence 2025 LABWARE TAIWAN CO., LTD. / 2026-05-29
- Next Generations Therapy Manufacturing LEVITRONIX GMBH TAIWAN BRANCH / 2026-05-29
- The Fastest and Safest Depth Filtration LEVITRONIX GMBH TAIWAN BRANCH / 2026-05-29
- Highest Cell Viability in Perfusion LEVITRONIX GMBH TAIWAN BRANCH / 2026-05-29
- SimTissue® by Lyson: The One-Stop Phantom Solution for Advanced Surgical Simulation LYSON MEDICAL TECHNOLOGY / 2026-05-27
- Top-Tier Laboratory Equipment Expert "Chuan Fu Technology" to Spark Innovation at BIO Asia-Taiwan CHUNG FU TECHNICAL DEVELOPMENT CO., LTD. / 2026-05-27
